Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 264 results found. Search for [ COVID-19 vaccine trials China ]

Results 180 to 200 of 264
Reuters
July 2, 2020
The three genomes showed the greatest resemblance to cases in Europe from February to May, and to cases in South and Southeast Asia from May to June


BusinessToday.In
July 2, 2020
Coronavirus Vaccine Latest News: With the news of the Oxford University-AstraZeneca vaccine in its last stage of clinical trials, hopes are high for an earlier than expected arrival of a COVID-19 vaccine


BusinessToday.In
July 2, 2020
Stock Market LIVE Updates on July 2: ONGC, followed by M&M, IndusInd Bank, HDFC Bank, SBI and Titan were among the top gainers in the Sensex pack. On the other hand, Tech Mahindra and HUL were the top laggards


BusinessToday.In
June 30, 2020
Coronavirus vaccine update: The Hyderabad-based vaccine major's vaccine candidate COVAXIN has received permission for advancing to human trials


E Kumar Sharma
June 29, 2020
DCGI has allowed Bharat Biotech to conduct phase I and II human trials for COVAXIN that will begin in July; a finished vaccine is expected to be rolled out in 3-4 months if all goes according to plan


Reuters
June 29, 2020
The Ad5-nCoV is one of China's eight vaccine candidates approved for human trials at home and abroad for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada


BusinessToday.In
June 29, 2020
With the news of the Oxford University-AstraZeneca vaccine in its last-stage trial, the world is hopeful of an earlier than expected arrival of a COVID-19 vaccine


Reuters
June 29, 2020
The vaccine candidate was developed jointly by CanSino and the Beijing Institute of Biotechnology in the Academy of Military Medical Sciences


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


BusinessToday.In
New Delhi, June 25, 2020
Coronavirus vaccine news: Johnson and Johnson has expedited its trials for the COVID vaccine. The final stage of the trial expected to begin in September has been pushed up to the second half of July


BusinessToday.In
New Delhi, June 24, 2020
Coronavirus vaccine news: Researchers at Imperial College London have administered their coronavirus vaccine to the first healthy volunteer; South Africa has initiated clinical trials of the University of Oxford candidate


BusinessToday.In
June 23, 2020
Ramdev Patanjali's corona medicine: Earlier this month, Balkrishna had claimed that ayurvedic medicine developed by Patanjali was able to cure at least 1,000 coronavirus patients within 5-14 days


PB Jayakumar
New Delhi, June 20, 2020
Glenmark developed active pharmaceutical ingredient and formulation for FabiFlu through in-house R&D; DCGI allowed fasttrack trials with Phase III in limited patients; approval process is also under Emergency Use Authorisation


Reuters
June 19, 2020
China, where the virus first originated last year, saw less than 10 new local cases reported daily on average in May, making it less favorable for a late-stage clinical trial


BusinessToday.In
New Delhi, June 16, 2020
Coronavirus treatment update: The steroid treatment has cut death rates by around one-third among those with the most severe cases of COVID-19 infection, according to trial by scientists leading the UK-led clinical trial known as RECOVERY


Reuters
June 16, 2020
No vaccines have been solidly proven to be able to effectively protect people from the virus that has killed more than 400,000 people, while multiple candidates are in various stages of development globally


BusinessToday.In
New Delhi, June 15, 2020
Coronavirus vaccine update: The Health Ministry has included the use of antiviral drug Remdesivir as part of its investigational therapy for restricted emergency use


Associated Press
June 14, 2020
AstraZeneca plans to begin delivering the vaccine to European countries by the end of this year under the agreement with the Inclusive Vaccine Alliance, formed this month by France, Germany, Italy and the Netherlands


BusinessToday.In
New Delhi, June 13, 2020
COVID-19 vaccine and drug latest news update: Gilead Sciences Inc had previously signed pacts with five other companies for manufacturing and sale of remdesivir; here are latest updates from across world on coronavirus vaccine developments


PAGES 10 OF 14  678910